Paper22992175
The influence of lipophilicity in drug discovery and design.
Arnott JA and 1 other. Expert Opin Drug Discov, 2012. Cited by 552 papers, by iCite.
Cite this record
ConductScience Library. The influence of lipophilicity in drug discovery and design. Papers, record 22992175. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22992175
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Discovery | Major topic |
| Pharmaceutical Preparations | Major topic |
| 1-Octanol | |
| Absorption | |
| Animals | |
| Humans | |
| Water |
Source PubMed
Cited by262
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 552 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42923404 | Rapid HPLC-Based ADME Profiling of Novel Donepezil and Rivastigmine Analogues for Potential Application in Alzheimer's Disease. | ACS Omega | 2026 | https://conductscience.org/library/papers/42923404 | PubMed |
| 42912899 | AI Accelerated Chemical Screening Integrates ChemBERTa to Identify Repositionable CASP4 Inhibitors via MD Simulations and MM/PBSA Analysis. | J Chem Inf Model | 2026 | https://conductscience.org/library/papers/42912899 | PubMed |
| 42908241 | Scaffold-Hunting From Pyriproxyfen: A Biochemoinformatic Route to Novel Insecticidal Leads. | Biomed Res Int | 2026 | https://conductscience.org/library/papers/42908241 | PubMed |
| 42850937 | Synthesis, Antiparasitic Activity, and ADME Profile of Morpholinephenylbenzamides: A Pharmacological Study Against Chagas Disease and Visceral Leishmaniasis. | ChemMedChem | 2026 | https://conductscience.org/library/papers/42850937 | PubMed |
| 42820474 | tris-Schiff Base Derivatives Containing Flurbiprofen as Potential Tyrosinase Inhibitors: Synthesis, In Vitro Evaluation, Molecular Docking, DFT and Dynamics Simulations. | Chem Biodivers | 2026 | https://conductscience.org/library/papers/42820474 | PubMed |
| 42779713 | Machine Learning-Guided Discovery of Bacterial-Selective Membrane-Active Compounds Reveals Mechanistic Bias in Antibiotic Training Datasets. | bioRxiv | 2026 | https://conductscience.org/library/papers/42779713 | PubMed |
| 42776425 | Discovery of potent and selective MAO-B inhibitors from a morpholine-substituted chalcone library for neurodegenerative disorders. | Mol Divers | 2026 | https://conductscience.org/library/papers/42776425 | PubMed |
| 42716976 | Integrated experimental and computational evaluation of atractylenolide III from Tubipora musica for anticancer lead identification. | Sci Rep | 2026 | https://conductscience.org/library/papers/42716976 | PubMed |
| 42690606 | Unveiling the anticancer potential of genus Aerva as therapeutics for CLL (Chronic Lymphocytic Leukemia): from plant to patient. | Folia Microbiol (Praha) | 2026 | https://conductscience.org/library/papers/42690606 | PubMed |
| 42678301 | Experimental and In Silico Evaluation of Honey-Derived Phenolic Compounds: Antioxidant Activity, Anti-Inflammatory Potential Pharmacokinetic Properties, Toxicity Assessment, and Multitarget Anti-Inflammatory Potential. | Oxid Med Cell Longev | 2026 | https://conductscience.org/library/papers/42678301 | PubMed |
| 42660646 | A New Sustainable Approach to Antibiotic Resistance: Development of bis-Quaternary Ammonium Salts From 2,4,6-Trichloro-1,3,5-Triazine. | ChemMedChem | 2026 | https://conductscience.org/library/papers/42660646 | PubMed |
| 42633343 | Experimentally derived biomimetic chromatographic descriptors for drug-induced phospholipidosis liability prediction. | ADMET DMPK | 2026 | https://conductscience.org/library/papers/42633343 | PubMed |
| 42588417 | LogPpred: An AI-Based Predictive Model for Accurate Estimation of Molecular LogP. | Molecules | 2026 | https://conductscience.org/library/papers/42588417 | PubMed |
| 42552512 | New 1,2,3-Triazole Hybrids as Anticancer Agents: Design, Synthesis, Characterization, and In Silico Studies. | ChemMedChem | 2026 | https://conductscience.org/library/papers/42552512 | PubMed |
| 42511653 | Integral Lipophilicity Studies with in Silico ADMET Parameter Analysis of Novel Pseudothiohydantoin Derivatives. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42511653 | PubMed |
| 42420190 | Hit-To-Lead Optimization of a Pyridylpiperazine Class Against Malaria: Pharmacokinetic Profile and In Vivo Efficacy of Optimized Compounds. | ChemMedChem | 2026 | https://conductscience.org/library/papers/42420190 | PubMed |
| 42357520 | Homomultimeric FAP Inhibitor-Based Radioligands for Cancer Theranostics: Design Principles, Structure-Function Relationships, and Preclinical Performance. | Molecules | 2026 | https://conductscience.org/library/papers/42357520 | PubMed |
| 42357408 | Bioassay-Guided Phytochemical Investigation of Vietnamese Vitex rotundifolia Leaves and the Liverwort Ptychanthus striatus as Sources of SARS-CoV-2 Main Protease Inhibitors. | Molecules | 2026 | https://conductscience.org/library/papers/42357408 | PubMed |
| 42327090 | Machine Learning-Guided Discovery of Bacterial-Selective Membrane-Active Compounds Reveals Mechanistic Bias in Antibiotic Training Datasets. | bioRxiv | 2026 | https://conductscience.org/library/papers/42327090 | PubMed |
| 42318538 | Discovery of novel InhA inhibitors through structural bioinformatics and machine learning-driven QSAR screening of natural products. | Biol Methods Protoc | 2026 | https://conductscience.org/library/papers/42318538 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22992175
GET https://conductscience.org/api/papers/v1/22992175/cited_by?page=2